BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitale I, Yamazaki T, Wennerberg E, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends Cancer 2021;7:557-72. [PMID: 33446447 DOI: 10.1016/j.trecan.2020.12.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 von Hofsten S, Paulsen MH, Magnussen SN, Ausbacher D, Kranz M, Bayer A, Strøm MB, Berge G. The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19597-4] [Reference Citation Analysis]
2 Koo DJ, Sut TN, Tan SW, Yoon BK, Jackman JA. Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge. IJMS 2022;23:10558. [DOI: 10.3390/ijms231810558] [Reference Citation Analysis]
3 Lu F, Zhu Y, Zhang G, Liu Z. Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. Front Pharmacol 2022;13:944147. [DOI: 10.3389/fphar.2022.944147] [Reference Citation Analysis]
4 Yin H, Chen X, Chi Q, Ma Y, Fu X, Du S, Qi Y, Wang K. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. Acta Pharmacol Sin. [DOI: 10.1038/s41401-022-00939-x] [Reference Citation Analysis]
5 Tang T, Huang X, Zhang G, Liang T. Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity. J Immunother Cancer 2022;10:e005065. [PMID: 35851309 DOI: 10.1136/jitc-2022-005065] [Reference Citation Analysis]
6 Tang T, Huang X, Zhang G, Lu M, Hong Z, Wang M, Huang J, Zhi X, Liang T. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. J Immunother Cancer 2022;10:e004129. [PMID: 35288467 DOI: 10.1136/jitc-2021-004129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Trinidad-Calderón PA, Varela-Chinchilla CD, García-Lara S. Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics. Molecules 2021;26:7453. [PMID: 34946535 DOI: 10.3390/molecules26247453] [Reference Citation Analysis]
8 Trinidad-calderón PA, Varela-chinchilla CD, García-lara S. Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics. Molecules 2021;26:7453. [DOI: 10.3390/molecules26247453] [Reference Citation Analysis]
9 Yamazaki T, Wennerberg E, Hensler M, Buqué A, Kraynak J, Fucikova J, Zhou XK, Sveinbjørnsson B, Rekdal Ø, Demaria S, Galluzzi L. LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology 2021;10:1962592. [PMID: 34408925 DOI: 10.1080/2162402X.2021.1962592] [Reference Citation Analysis]
10 Galluzzi L, Garg AD. Immunology of Cell Death in Cancer Immunotherapy. Cells 2021;10:1208. [PMID: 34063358 DOI: 10.3390/cells10051208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Wu Y, Lu D, Jiang Y, Jin J, Liu S, Chen L, Zhang H, Zhou Y, Chen H, Nagle DG, Luan X, Zhang W. Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma. J Med Chem 2021;64:5802-15. [PMID: 33844923 DOI: 10.1021/acs.jmedchem.0c02237] [Reference Citation Analysis]